Endoscopic radiofrequency ablation for malignant biliary strictures

Wang,Fei; Li,Quanpeng; Zhang,Xiuhua; Jiang,Guobing; Ge,Xianxiu; Yu,Hong; Nie,Junjie; Ji,Guozhong; Miao,Lin

doi:10.3892/etm.2016.3235

Endoscopic radiofrequency ablation for malignant biliary strictures

Authors:
- Fei Wang
- Quanpeng Li
- Xiuhua Zhang
- Guobing Jiang
- Xianxiu Ge
- Hong Yu
- Junjie Nie
- Guozhong Ji
- Lin Miao
View Affiliations

Affiliations: Medical Center for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210011, P.R. China
Published online on: April 6, 2016 https://doi.org/10.3892/etm.2016.3235
Pages: 2484-2488

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Endoscopic radiofrequency ablation (RFA) is a novel palliation therapy for malignant biliary stricture; however, its feasibility and safety has not yet been clearly defined. The aim of the present study was to evaluate the feasibility and safety of endoscopic RFA for the treatment of malignant biliary strictures. A total of 12 patients treated by endoscopic RFA between December 2011 and October 2013 were retrospectively analyzed. Adverse events within 30 days post‑intervention, stricture diameters prior to and following RFA, stent patency and survival time were investigated. A total of 12 patients underwent 20 RFA procedures as a treatment for malignant biliary strictures. Two patients required repeated elective RFA (4 and 6 times, respectively). All 20 RFA procedures were successfully performed without technical problems. During a 30 day period following each RFA procedure, two patients experienced fever (38.2 and 38.9˚C, respectively) and another patient exhibited post‑endoscopic retrograde cholangiopancreatography pancreatitis. The 30‑ and 90‑day mortality rates were 0 and 8.3%, respectively. Mean stricture diameter prior to RFA was 5.3 mm (standard deviation (SD), 0.9 mm; range, 5‑8 mm), and the mean diameter following RFA was 12.6 mm (SD, 3.1 mm; range, 8‑15 mm). There was a significant increase of 7.3 mm in the bile duct diameter following RFA in comparison with prior to RFA (t=8.6; P≤0.001). Of the 11 patients with stents inserted following RFA, the median stent patency was 125.0 days [95% confidence interval (CI), 94.7‑155.3 days]. Extrapolated median survival following the first RFA was 232 days (95% CI, 94.3‑369.7 days). In conclusion, RFA appears to be an efficient and safe treatment strategy for the palliation of unresectable malignant biliary strictures.

View Figures

View References

1	Webb K and Saunders M: Endoscopic management of malignant bile duct strictures. Gastrointest Endosc Clin N Am. 23:313–331. 2013. View Article : Google Scholar : PubMed/NCBI
2	Moss AC, Morris E, Leyden J and MacMathuna P: Malignant distal biliary obstruction: A systematic review and meta-analysis of endoscopic and surgical bypass results. Cancer Treat Rev. 33:213–221. 2007. View Article : Google Scholar : PubMed/NCBI
3	Shepherd HA, Royle G, Ross AP, Diba A, Arthur M and Colin-Jones D: Endoscopic biliary endoprosthesis in the palliation of malignant obstruction of the distal common bile duct: A randomized trial. Br J Surg. 75:1166–1168. 1988. View Article : Google Scholar : PubMed/NCBI
4	Andersen JR, Sorensen SM, Kruse A, Rokkjaer M and Matzen P: Randomised trial of endoscopic endoprosthesis versus operative bypass in malignant obstructive jaundice. Gut. 30:1132–1135. 1989. View Article : Google Scholar : PubMed/NCBI
5	Kaassis M, Boyer J, Dumas R, Ponchon T, Coumaros D, Delcenserie R, Canard JM, Fritsch J, Rey JF and Burtin P: Plastic or metal stents for malignant stricture of the common bile duct? Results of a randomized prospective study. Gastrointest Endosc. 57:178–182. 2003. View Article : Google Scholar : PubMed/NCBI
6	Soderlund C and Linder S: Covered metal versus plastic stents for malignant common bile duct stenosis: A prospective, randomized, controlled trial. Gastrointest Endosc. 63:986–995. 2006. View Article : Google Scholar : PubMed/NCBI
7	Hong W, Sun X and Zhu Q: Endoscopic stenting for malignant hilar biliary obstruction: Should it be metal or plastic and unilateral or bilateral? Eur J Gastroenterol Hepatol. 25:1105–1112. 2013. View Article : Google Scholar : PubMed/NCBI
8	Donelli G, Guaglianone E, Di Rosa R, Fiocca F and Basoli A: Plastic biliary stent occlusion: factors involved and possible preventive approaches. Clin Med Res. 5:53–60. 2007. View Article : Google Scholar : PubMed/NCBI
9	Loew BJ, Howell DA, Sanders MK, Desilets DJ, Kortan PP, May GR, Shah RJ, Chen YK, Parsons WG, Hawes RH, et al: Comparative performance of uncoated, self-expanding metal biliary stents of different designs in 2 diameters: Final results of an international multicenter, randomized, controlled trial. Gastrointest Endosc. 70:445–453. 2009. View Article : Google Scholar : PubMed/NCBI
10	Telford JJ, Carr-Locke DL, Baron TH, Poneros JM, Bounds BC, Kelsey PB, Schapiro RH, Huang CS, Lichtenstein DR, Jacobson BC, et al: A randomized trial comparing uncovered and partially covered self-expandable metal stents in the palliation of distal malignant biliary obstruction. Gastrointest Endosc. 72:907–914. 2010. View Article : Google Scholar : PubMed/NCBI
11	Kullman E, Frozanpor F, Söderlund C, Linder S, Sandström P, Lindhoff-Larsson A, Toth E, Lindell G, Jonas E, Freedman J, et al: Covered versus uncovered self-expandable nitinol stents in the palliative treatment of malignant distal biliary obstruction: results from a randomized, multicenter study. Gastrointest Endosc. 72:915–923. 2010. View Article : Google Scholar : PubMed/NCBI
12	Rumalla A, Baron TH, Wang KK, Gores GJ, Stadheim LM and de Groen PC: Endoscopic application of photodynamic therapy for cholangiocarcinoma. Gastrointest Endosc. 53:500–504. 2001. View Article : Google Scholar : PubMed/NCBI
13	Gao F, Bai Y, Ma SR, Liu F and Li ZS: Systematic review: Photodynamic therapy for unresectable cholangiocarcinoma. J Hepatobiliary Pancreat Sci. 17:125–131. 2010. View Article : Google Scholar : PubMed/NCBI
14	Bruix J and Sherman M: Management of hepatocellular carcinoma: an update. Hepatology. 53:1020–1022. 2011. View Article : Google Scholar : PubMed/NCBI
15	Siperstein AE, Berber E, Ballem N and Parikh RT: Survival after radiofrequency ablation of colorectal liver metastases: 10-Year experience. Ann Surg. 246:559–565. 2007. View Article : Google Scholar : PubMed/NCBI
16	Itoi T, Isayama H, Sofuni A, Itokawa F, Tamura M, Watanabe Y, Moriyasu F, Kahaleh M, Habib N, Nagao T, et al: Evaluation of effects of a novel endoscopically applied radiofrequency ablation biliary catheter using an ex-vivo pig liver. J Hepatobiliary Pancreat Sci. 19:543–547. 2012. View Article : Google Scholar : PubMed/NCBI
17	Zacharoulis D, Lazoura O, Sioka E, Potamianos S, Tzovaras G, Nicholls J, Koukoulis G and Habib N: Habib EndoHPB: A novel endobiliary radiofrequency ablation device. An experimental study. J Invest Surg. 26:6–10. 2013. View Article : Google Scholar : PubMed/NCBI
18	Steel AW, Postgate AJ, Khorsandi S, Nicholls J, Jiao L, Vlavianos P, Habib N and Westaby D: Endoscopically applied radiofrequency ablation appears to be safe in the treatment of malignant biliary obstruction. Gastrointest Endosc. 73:149–153. 2011. View Article : Google Scholar : PubMed/NCBI
19	Dolak W, Schreiber F, Schwaighofer H, Gschwantler M, Plieschnegger W, Ziachehabi A, Mayer A, Kramer L, Kopecky A, Schrutka-Kölbl C, et al: Endoscopic radiofrequency ablation for malignant biliary obstruction: A nationwide retrospective study of 84 consecutive applications. Surg Endosc. 28:854–860. 2014. View Article : Google Scholar : PubMed/NCBI
20	Bismuth H, Nakache R and Diamond T: Management strategies in resection for hilar cholangiocarcinoma. Ann Surg. 215:31–38. 1992. View Article : Google Scholar : PubMed/NCBI
21	Cho YK, Kim JK, Kim MY, Rhim H and Han JK: Systemic review of randomized trials for hepatocellular carcinoma treated with percutaneous ablation therapies. Hepatology. 49:453–459. 2009. View Article : Google Scholar : PubMed/NCBI
22	Izumi N: Recent advances of radiofrequency ablation for early hepatocellular carcinoma. J Gastroenterol Hepatol. 26(Suppl 1): S115–S122. 2011. View Article : Google Scholar
23	Wadsworth CA, Westaby D and Khan SA: Endoscopic radiofrequency ablation for cholangiocarcinoma. Curr Opin Gastroenterol. 29:305–311. 2013. View Article : Google Scholar : PubMed/NCBI
24	Tal AO, Vermehren J, Friedrich-Rust M, Bojunga J, Sarrazin C, Zeuzem S, Trojan J and Albert JG: Intraductal endoscopic radiofrequency ablation for the treatment of hilar non-resectable malignant bile duct obstruction. World J Gastrointest Endosc. 6:13–19. 2014. View Article : Google Scholar : PubMed/NCBI
25	Wang F, Li Q, Ge X, Yu H, Nie J and Miao L: Choledochoscopic radiofrequency ablation for congenital choledochal cysts. Endoscopy. 46(Suppl 1): E373–E374. 2014.PubMed/NCBI